Increased renal metabolism in diabetes
Both selective AMYR agonists, and dual CTR and AMYR agonists such as sCT 5,6,7 , have demonstrated efficacy in controlling appetite and body weight, however this is not seen with a CTR-selective agonist 9
Because some cancer therapies work by creating free radicals that kill cancer cells, high levels of antioxidants may neutralize these effects and protect cancer cells from these therapies
Exendin-4, a stable synthetic form of GLP-1, is commonly used clinically for diabetes treatment because GLP-1 has a short half-life (Drucker and Nauck, 2006
Even modest weight loss of 5 to 10 percent, achievable within the first 8 to 12 weeks for most researchers, produces disproportionate reductions in visceral fat that improve metabolic health markers
Peak blood levels occur roughly one to two days after injection